In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders (Record no. 67329)

MARC details
000 -LEADER
fixed length control field 02143naaaa2200313uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/50090
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220220051607.0
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number intechopen.72962
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789857177
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781789857184
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5772/intechopen.72962
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Houria Bachtarzi
Relationship auth
245 10 - TITLE STATEMENT
Title In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. IntechOpen
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic resource (198 p.)
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. Ongoing advances in pharmaceutical biotechnology have paved the way to ground-breaking new biological therapeutic modalities, offering the possibility of a durable curative approach for a number of life-threatening diseases, for which the medical need is as yet unmet. Over the past decades, gene therapy has seen a massive transformation from a proof-of-concept approach to a clinical reality culminating in the regulatory approval of state-of-the-art products in the European Union and in the United States. This book captures some of the scientific progresses notably in gene transfer technologies and translational development of in vivo and ex vivo gene therapy interventions in the treatment of a broad range of complex and debilitating non-inherited and inherited disorders such as: human immunodeficiency virus 1 (HIV-1) infection, cancer, cystic fibrosis, hereditary retinopathies, haemophilia B, cardiac diseases, and chronic liver fibrosis.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction All rights reserved
-- http://oapen.org/content/about-rights
546 ## - LANGUAGE NOTE
Language note English
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Life Sciences
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Molecular Genetics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Genetics and Molecular Biology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Genomics
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Biochemistry
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://www.intechopen.com/books/in-vivo-and-ex-vivo-gene-therapy-for-inherited-and-non-inherited-disorders">https://www.intechopen.com/books/in-vivo-and-ex-vivo-gene-therapy-for-inherited-and-non-inherited-disorders</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/50090">https://directory.doabooks.org/handle/20.500.12854/50090</a>
Access status 0
Public note DOAB: description of the publication

No items available.